Health Care sector

Drug makers, biotechnology firms, medical device makers, insurers, and health services providers.

Figures use XLV (Health Care Select Sector SPDR Fund) as an ETF proxy for the sector, compared with SPY (ETF proxy for the S&P 500).

Completed-session dataAs of session: Nov 17, 2026Last refreshed: Nov 17, 5:00 PM ETBenchmark: SPY (ETF proxy for the S&P 500)Methodology

Completed-session closes only. Figures can lag the market and are never intraday. Sector figures use ETF proxies. Source: Yahoo Finance via yahoo-finance2.

1D5D1M3MYTD1Y5Y5 years to the last completed session. Completed sessions only; no intraday values.

Performance against the benchmark

Health Care ETF proxy returns against SPY by period, completed sessions only.
PeriodXLVSPYDifferenceHoldings risingRange
1D-1.41%-1.01%-0.39 pp1 of 10Nov 16, 2026 to Nov 17, 2026
5D-1.93%-2.33%+0.40 pp0 of 10Nov 10, 2026 to Nov 17, 2026
1M+4.83%-4.04%+8.86 pp5 of 10Oct 16, 2026 to Nov 17, 2026
3M+11.31%-4.97%+16.28 pp8 of 10Aug 17, 2026 to Nov 17, 2026
YTD+21.15%+8.25%+12.90 pp9 of 10Dec 31, 2025 to Nov 17, 2026
1Y+24.15%+11.22%+12.93 pp9 of 10Nov 17, 2025 to Nov 17, 2026
5Y+50.25%+67.28%-17.03 pp7 of 10Nov 17, 2021 to Nov 17, 2026

Past 5 years, indexed to 100

XLV against SPY over the selected period. The sector line is blue and solid; SPY is amber and dashed.

XLV return
+50.25%
SPY return
+67.28%
Relative
-17.03 pp
Index at the end
150.3

Past 5 years. Indexed to 100 on Nov 17, 2021, through Nov 17, 2026. XLV ends at 150.3, up 50.25 percent; SPY ends at 167.3, up 67.28 percent.

XLV+50.25%SPY+67.28%Vertical axis: price index, start of range = 100; the dashed line marks that starting level. The crosshair reads the date, each series, its return from 100, and the difference from SPY where both have a value that session. Adjusted for distributions (total-return basis). Source: Yahoo Finance via yahoo-finance2. Benchmark: SPY. Range: Nov 17, 2021 to Nov 17, 2026. Hover, touch, or focus the chart and use the arrow keys to read exact values.
Show chart values as a table
Sampled index values for Past 5 years.
DateXLVSPY
Nov 17, 2021100.0 (0.0%)100.0 (0.0%)
May 2, 202297.5 (-2.5%)89.1 (-10.9%)
Oct 14, 202294.1 (-5.9%)77.5 (-22.5%)
Mar 30, 202398.0 (-2.0%)88.3 (-11.7%)
Sep 12, 2023102.0 (+2.0%)97.9 (-2.1%)
Feb 26, 2024114.0 (+14.0%)111.9 (+11.9%)
Aug 9, 2024117.1 (+17.1%)118.6 (+18.6%)
Jan 22, 2025111.9 (+11.9%)135.8 (+35.8%)
Jul 7, 2025106.7 (+6.7%)139.9 (+39.9%)
Dec 19, 2025123.6 (+23.6%)154.2 (+54.2%)
Jun 4, 2026122.3 (+22.3%)172.0 (+72.0%)
Nov 17, 2026150.3 (+50.3%)167.3 (+67.3%)

Relative performance

XLV return minus the SPY return, in percentage points. The selected period is marked. A missing bar means that period did not pass the quality checks.

XLV return minus SPY, by period, in percentage points−20−100+10+20Return minus SPY return, percentage points1D▼ -0.39 pp5D▲ +0.40 pp1M▲ +8.86 pp3M▲ +16.28 ppYTD▲ +12.90 pp1Y▲ +12.93 pp5Y▼ -17.03 pp
Each bar is the published period figure. Nothing is filled in for a period that has no figure.

Risk and trend measures

1-year volatility (annualised)
16.9%
Worst peak-to-trough fall, 1 year
-10.47%
Versus 50-day average
Above
Transparent sector score
76 / 100

Rotation group:Top groupLeading

In the top group of sectors on this measure. Weighted relative momentum versus the benchmark is +15.1 percentage points. 50% of covered holdings rose over the past month. The sector proxy is above its 50-day average.

The score is a descriptive percentile blend of momentum, stability, drawdown, and breadth across the eleven sectors. It is not a rating or a recommendation. See the formula.

Industry breakdown

  • Pharmaceuticals
  • Biotechnology
  • Medical equipment
  • Managed care
  • Health care services

Industries are the typical groups inside this sector. Industry-level returns need licensed classification data and are not shown.

What tends to drive it

  • Drug and device approvals
  • Patent expirations
  • Reimbursement and drug-pricing policy
  • Aging populations

Risks to understand

  • Clinical trial and approval outcomes are uncertain
  • Pricing and policy changes can hit earnings
  • Patent cliffs reduce revenue

Largest holdings of the ETF proxy

Largest disclosed holdings only (10 of 10 requested). Holdings dates are not published by the source. They represent about 61% of the fund.

XLV largest holdings, past 5 years return−1000+100+200+300+400+5005Y returnLLY▲ +466.00%GILD▲ +201.58%ABBV▲ +198.02%AMGN▲ +157.78%MRK▲ +102.26%JNJ▲ +96.27%TMO▲ +9.32%UNH▼ -4.99%ABT▼ -10.07%PFE▼ -26.66%
5 years to the last completed session. Completed sessions only. A holding without a checked return is marked unavailable and is not drawn as zero.
Largest holdings of XLV with returns and trend, completed sessions only.
HoldingWeight5Y return1M vs sector1Y volatility50-day trend
LLYEli Lilly and Co16.9%+466.00%+7.92 pp35.2%Above
JNJJohnson & Johnson9.8%+96.27%+4.23 pp21.1%Above
ABBVAbbVie Inc7.8%+198.02%-2.23 pp25.2%Above
MRKMerck & Co Inc5.5%+102.26%-6.59 pp29.9%Below
UNHUnitedHealth Group Inc5.4%-4.99%-7.75 pp34.7%Below
TMOThermo Fisher Scientific Inc3.8%+9.32%-5.29 pp30.1%Above
AMGNAmgen Inc3.7%+157.78%+1.06 pp28.7%Above
GILDGilead Sciences Inc3.1%+201.58%+4.18 pp27.3%Above
ABTAbbott Laboratories2.7%-10.07%-5.00 pp28.5%Above
PFEPfizer Inc2.6%-26.66%-7.17 pp21.1%Below

Breadth and this table cover the largest disclosed holdings only, not every company in the sector. Holdings dates are not published by the source.

Recent headlines

Headlines link to their publishers and are shown as context only. They are not tied to price moves and are not recommendations.

Rotation quadrant

Health Care is marked in blue. The axes stay on the published 3-month and 1-month windows, so this chart does not follow the period selector.

Sector rotation quadrant chartHorizontal axis: three-month return relative to SPY in percentage points. Vertical axis: change in momentum, one-month relative return minus the three-month monthly average. The same values are listed in the table below.−20−100+10+20−7.5−5.0−2.50+2.5+5.0+7.5IMPROVINGLEADINGLAGGINGWEAKENING3-month return vs SPY, percentage points →Momentum change, percentage points →Technology (XLK): -9.1 pp vs SPY over 3 months; momentum change -3.9 ppFinancials (XLF): +4.4 pp vs SPY over 3 months; momentum change +5.3 ppConsumer Discretionary (XLY): +5.5 pp vs SPY over 3 months; momentum change +6.3 ppCommunication Services (XLC): +0.3 pp vs SPY over 3 months; momentum change -0.6 ppHealth Care (XLV): +16.3 pp vs SPY over 3 months; momentum change +3.4 ppIndustrials (XLI): -6.4 pp vs SPY over 3 months; momentum change +4.4 ppConsumer Staples (XLP): +13.7 pp vs SPY over 3 months; momentum change +3.9 ppEnergy (XLE): +6.8 pp vs SPY over 3 months; momentum change -5.4 ppMaterials (XLB): +2.7 pp vs SPY over 3 months; momentum change +3.0 ppReal Estate (XLRE): +3.0 pp vs SPY over 3 months; momentum change +6.4 ppUtilities (XLU): +4.0 pp vs SPY over 3 months; momentum change +5.6 pp
▲ top group · ■ middle group · ▼ bottom group, from the published rotation rule. Position is descriptive and is not a forecast. The quadrant uses fixed 3-month and 1-month windows set by that rule, so it does not change with the period selector above; the bar chart does. XLV is marked in blue.

Stored rotation history

Rotation groups stored for Health Care on past sessions, with the later outcome where one exists.
SessionGroupQuadrantOutcome
Nov 17, 2026Top groupLeadingPending
Nov 16, 2026Top groupLeadingPending
Nov 13, 2026Top groupLeadingPending
Nov 12, 2026Top groupLeadingPending
Nov 11, 2026Top groupLeadingPending
Nov 10, 2026Top groupLeadinghit

Source: Yahoo Finance via yahoo-finance2 (Reference use only; not a redistribution licence). Session: Nov 17, 2026. Method versions: sector-metrics-v1, sector-score-v1, rotation-v1, gics-11-etf-proxy-v1. Prices are adjusted for distributions. How these figures are built

Sector Intelligence is educational research. It describes what sector ETF proxies did over completed sessions and how a transparent rule groups them. It is not investment advice, a recommendation to buy or sell, or a prediction. Past performance does not indicate future results.